Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Kondo, Shunsuke"'
Autor:
Yamamoto N; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan., Kuboki Y; Department of Experimental Therapeutics, National Cancer Center Hospital East, Chiba, Japan., Harano K; Department of Experimental Therapeutics, National Cancer Center Hospital East, Chiba, Japan., Koyama T; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan., Kondo S; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan., Hagiwara A; Research and Development Division, Janssen Pharmaceutical K.K., Tokyo, Japan., Suzuki N; Research and Development Division, Janssen Pharmaceutical K.K., Tokyo, Japan., Fujikawa E; Research and Development Division, Janssen Pharmaceutical K.K., Tokyo, Japan., Toyoizumi K; Research and Development Division, Janssen Pharmaceutical K.K., Tokyo, Japan., Mukai M; Research and Development Division, Janssen Pharmaceutical K.K., Tokyo, Japan., Doi T; Department of Experimental Therapeutics, National Cancer Center Hospital East, Chiba, Japan. tdoi@east.ncc.go.jp.
Publikováno v:
Investigational new drugs [Invest New Drugs] 2024 Aug; Vol. 42 (4), pp. 376-385. Date of Electronic Publication: 2024 Jun 04.
Autor:
Yamamoto N; Department of Experimental Therapeutics, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-Ku, Tokyo, 104-0045, Japan. nbryamam@ncc.go.jp., Koyama T; Department of Experimental Therapeutics, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-Ku, Tokyo, 104-0045, Japan., Sato J; Department of Experimental Therapeutics, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-Ku, Tokyo, 104-0045, Japan., Yoshida T; Department of Experimental Therapeutics, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-Ku, Tokyo, 104-0045, Japan., Sudo K; Department of Experimental Therapeutics, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-Ku, Tokyo, 104-0045, Japan., Iwasa S; Department of Experimental Therapeutics, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-Ku, Tokyo, 104-0045, Japan., Kondo S; Department of Experimental Therapeutics, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-Ku, Tokyo, 104-0045, Japan., Yonemori K; Department of Experimental Therapeutics, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-Ku, Tokyo, 104-0045, Japan., Kawasaki A; Chugai Pharmaceutical Co., Ltd, 1-1 Nihonbashi-Muromachi 2-Chome Chuo-Ku, Tokyo, 103-8324, Japan., Satake K; Chugai Pharmaceutical Co., Ltd, 1-1 Nihonbashi-Muromachi 2-Chome Chuo-Ku, Tokyo, 103-8324, Japan., Shibata S; Chugai Pharmaceutical Co., Ltd, 1-1 Nihonbashi-Muromachi 2-Chome Chuo-Ku, Tokyo, 103-8324, Japan., Shimizu T; Department of Experimental Therapeutics, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-Ku, Tokyo, 104-0045, Japan.
Publikováno v:
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2024 Jul; Vol. 94 (1), pp. 109-115. Date of Electronic Publication: 2024 Jan 11.
Autor:
Kuboki Y; Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan., Koyama T; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan., Matsubara N; Department of Breast and Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan., Naito Y; Department of General Internal Medicine, National Cancer Center Hospital East, Kashiwa, Japan., Kondo S; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan., Harano K; Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan., Yonemori K; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan., Yoh K; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan., Gu Y; Incyte Corporation, Wilmington, Delaware, USA., Mita T; Incyte Biosciences Japan G.K., Tokyo, Japan., Chen X; Incyte Corporation, Wilmington, Delaware, USA., Ueda E; Incyte Biosciences Japan G.K., Tokyo, Japan., Yamamoto N; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan., Doi T; Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan., Shimizu T; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.; Department of Medical Oncology/Cancer Center, Wakayama Medical University Hospital, Wakayama Medical University Graduate School of Medicine, Wakayama, Japan.
Publikováno v:
Cancer medicine [Cancer Med] 2024 Apr; Vol. 13 (8), pp. e6980.
Autor:
Kondo S; Department of Experimental Therapeutics, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan. Electronic address: shkondo@ncc.go.jp., Katsuya Y; Department of Experimental Therapeutics, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan., Yonemori K; Department of Experimental Therapeutics, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan., Komuro K; Research and Development, AstraZeneca K.K., 3-1-1, Shibaura, Minato-ku, Tokyo, 108-0023, Japan., Sugeno M; Research and Development, AstraZeneca K.K., 3-1, Ofuka-cho, Kita-ku, Osaka, 530-0011, Japan., Kawata T; Research and Development, AstraZeneca K.K., 3-1, Ofuka-cho, Kita-ku, Osaka, 530-0011, Japan., Ghiorghiu D; Late Development Oncology, AstraZeneca, City House, 132 Hills Road, Cambridge, CB2 1RY, UK., Meulendijks D; Late Development Oncology, AstraZeneca, City House, 132 Hills Road, Cambridge, CB2 1RY, UK., Yamamoto N; Department of Experimental Therapeutics, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
Publikováno v:
Cancer treatment and research communications [Cancer Treat Res Commun] 2024; Vol. 39, pp. 100809. Date of Electronic Publication: 2024 Mar 24.
Autor:
Satake T; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan., Kondo S; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.; Outpatient Treatment Center, National Cancer Center Hospital, Tokyo, Japan., Tanabe N; Genetic Medicine and Services, National Cancer Center Hospital, Tokyo, Japan., Mizuno T; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan., Katsuya Y; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan., Sato J; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan., Koyama T; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan., Yoshida T; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan., Hirata M; Genetic Medicine and Services, National Cancer Center Hospital, Tokyo, Japan., Yamamoto N; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.
Publikováno v:
Cancer research communications [Cancer Res Commun] 2023 Nov 14; Vol. 3 (11), pp. 2302-2311.
Autor:
Uehara Y; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.; Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.; Department of Precision Cancer Medicine, Center for Innovative Cancer Treatment, Tokyo Medical and Dental University, Tokyo, Japan., Koyama T; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan., Katsuya Y; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan., Sato J; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan., Sudo K; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Kondo S; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan., Yoshida T; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan., Shoji H; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.; Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Shimoi T; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Yonemori K; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Yamamoto N; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
Publikováno v:
JAMA network open [JAMA Netw Open] 2023 Sep 05; Vol. 6 (9), pp. e2333188. Date of Electronic Publication: 2023 Sep 05.
Autor:
Ida H; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan., Shimizu T; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan., Nishino M; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan., Nakamura Y; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan., Yazaki S; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Katsuya Y; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan., Sato J; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan., Koyama T; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan., Iwasa S; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.; Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Sudo K; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Kondo S; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan., Yonemori K; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.; Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Shitara K; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan.; Department of Immunology, Nagoya University Graduate School of Medicine, Nagoya, Japan., Shiono S; Oncology Early Clinical Operation II, Ono Pharmaceutical Co., Ltd., Osaka, Japan., Matsuoka D; Japan and Asia Clinical Development Department, Oncology Business Group, Eisai Co., Ltd., Tokyo, Japan., Yasuda K; Japan and Asia Clinical Development Department, Oncology Business Group, Eisai Co., Ltd., Tokyo, Japan., Otake Y; Japan and Asia Clinical Development Department, Oncology Business Group, Eisai Co., Ltd., Tokyo, Japan., Suzuki T; Japan and Asia Clinical Development Department, Oncology Business Group, Eisai Co., Ltd., Tokyo, Japan., Takase T; Clinical Data Science Department, Medicine Development Center, Eisai Co., Ltd., Tokyo, Japan., Takashima S; Clinical Data Science Department, Medicine Development Center, Eisai Co., Ltd., Tokyo, Japan., Yamaguchi K; Clinical Pharmacology Science Department, Medicine Development Center, Eisai Co., Ltd., Tokyo, Japan., Semba T; Oncology Tsukuba Research Department, Oncology Business Group, Eisai Co., Ltd., Ibaraki, Japan., Yamamoto N; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
Publikováno v:
Cancer research communications [Cancer Res Commun] 2023 Jul 10; Vol. 3 (7), pp. 1189-1199. Date of Electronic Publication: 2023 Jul 10 (Print Publication: 2023).
Autor:
Takamizawa S; Department of Experimental Therapeutics, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan., Katsuya Y; Department of Experimental Therapeutics, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan. ykatsuya@ncc.go.jp., Chen YN; Department of Ophthalmic Oncology, National Cancer Center Hospital, Tokyo, Japan., Mizuno T; Department of Experimental Therapeutics, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan., Koyama T; Department of Experimental Therapeutics, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan., Sudo K; Department of Experimental Therapeutics, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan., Yoshida T; Department of Experimental Therapeutics, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan., Kondo S; Department of Experimental Therapeutics, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan., Iwasa S; Department of Experimental Therapeutics, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan., Yonemori K; Department of Experimental Therapeutics, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan., Shimizu T; Department of Experimental Therapeutics, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan., Yamamoto N; Department of Experimental Therapeutics, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan., Suzuki S; Department of Ophthalmic Oncology, National Cancer Center Hospital, Tokyo, Japan.
Publikováno v:
Investigational new drugs [Invest New Drugs] 2023 Feb; Vol. 41 (1), pp. 173-181. Date of Electronic Publication: 2022 Dec 05.
Autor:
Matsuzaki J; Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan.; Division of Pharmacotherapeutics, Keio University Faculty of Pharmacy, Minato-ku, Tokyo, Japan., Kato K; Department of Head and Neck, Esophageal Medical Oncology and Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan., Oono K; Preferred Networks, Inc, Chiyoda-ku, Tokyo, Japan., Tsuchiya N; Laboratory of Molecular Carcinogenesis, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan., Sudo K; Department of Breast and Medical Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan., Shimomura A; Department of Breast and Medical Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan., Tamura K; Department of Breast and Medical Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan., Shiino S; Department of Breast Surgery, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan., Kinoshita T; Department of Breast Surgery, National Hospital Organization Tokyo Medical Center, Meguro-ku, Tokyo, Japan., Daiko H; Department of Esophageal Surgery, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan., Wada T; Department of Gastric Surgery, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan., Katai H; Department of Gastric Surgery, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan., Ochiai H; Department of Colorectal Surgery, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan., Kanemitsu Y; Department of Colorectal Surgery, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan., Takamaru H; Endoscopy Division, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan., Abe S; Endoscopy Division, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan., Saito Y; Endoscopy Division, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan., Boku N; Department of Head and Neck, Esophageal Medical Oncology and Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan., Kondo S; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan., Ueno H; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan., Okusaka T; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan., Shimada K; Department of Hepatobiliary and Pancreatic Surgery, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan., Ohe Y; Department of Thoracic Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan., Asakura K; Department of Thoracic Surgery, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan., Yoshida Y; Department of Thoracic Surgery, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan., Watanabe SI; Department of Thoracic Surgery, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan., Asano N; Department of Musculoskeletal Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan., Kawai A; Department of Musculoskeletal Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan., Ohno M; Department of Neurosurgery and Neuro-Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan., Narita Y; Department of Neurosurgery and Neuro-Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan., Ishikawa M; Department of Gynecology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan., Kato T; Department of Gynecology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan., Fujimoto H; Department of Urology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan., Niida S; Research Institute, National Center for Geriatrics and Gerontology, Obu, Aichi, Japan., Sakamoto H; Department of Biobank and Tissue Resources, Fundamental Innovative Oncology Core, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan., Takizawa S; Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan.; Toray Industries, Inc, Kamakura, Kanagawa, Japan., Akiba T; Preferred Networks, Inc, Chiyoda-ku, Tokyo, Japan., Okanohara D; Preferred Networks, Inc, Chiyoda-ku, Tokyo, Japan., Shiraishi K; Division of Genome Biology, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan., Kohno T; Division of Genome Biology, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan., Takeshita F; Department of Translational Oncology, Fundamental Innovative Oncology Core, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan., Nakagama H; National Cancer Center, Chuo-ku, Tokyo, Japan., Ota N; Preferred Medicine, Inc, Burlingame, CA, USA., Ochiya T; Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan.; Department of Molecular and Cellular Medicine, Tokyo Medical University, Shinjuku-ku, Tokyo, Japan.
Publikováno v:
JNCI cancer spectrum [JNCI Cancer Spectr] 2023 Jan 03; Vol. 7 (1).
Autor:
Kondo S; National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. shkondo@ncc.go.jp., Iwasa S; National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan., Koyama T; National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan., Fujita T; AstraZeneca K.K., 3-1, Ofuka-cho, Kita-ku, Osaka, 530-0011, Japan., Sugibayashi K; AstraZeneca K.K., 3-1-1, Shibaura, Minato-ku, Tokyo, 108-0023, Japan.; AstraZeneca, 136 Hills Road, Cambridge, CB2 8PA, UK., Murayama K; AstraZeneca K.K., 3-1, Ofuka-cho, Kita-ku, Osaka, 530-0011, Japan., Yamamoto N; National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Publikováno v:
International journal of clinical oncology [Int J Clin Oncol] 2022 Dec; Vol. 27 (12), pp. 1795-1804. Date of Electronic Publication: 2022 Nov 07.